2025-10-28
October Literature Highlights | Publications Featuring abinScience Products
In October, multiple groundbreaking studies powered by abinScience’s high-quality antibodies and recombinant proteins were published in prestigious journals such as Pharmaceuticals, Cell Reports, and Chemical Engineering Journal. These works span key disease areas including intervertebral disc degeneration, cancer signaling, and Alzheimer’s disease. By providing core research materials for target validation, pathway analysis, and disease mechanism studies, abinScience contributed significantly to discoveries involving ferroptosis inhibition, CAR-T target identification, and neuroinflammation pathways. To acknowledge researchers’ trust and collaboration, abinScience has launched a Literature Citation Reward Program—encouraging more scientists to publish original work and advance biomedical innovation globally.
中文
English
